The process begins with the treatment of DNA with sodium bisulfite, which deaminates unmethylated cytosines to uracil while leaving methylated cytosines unchanged. The treated DNA is then amplified via PCR, during which uracil is replaced by thymine. Sequencing the amplified DNA allows for the differentiation between methylated and unmethylated cytosines.
